[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA201071180A1 - Конденсированные циклические соединения и их применение - Google Patents

Конденсированные циклические соединения и их применение

Info

Publication number
EA201071180A1
EA201071180A1 EA201071180A EA201071180A EA201071180A1 EA 201071180 A1 EA201071180 A1 EA 201071180A1 EA 201071180 A EA201071180 A EA 201071180A EA 201071180 A EA201071180 A EA 201071180A EA 201071180 A1 EA201071180 A1 EA 201071180A1
Authority
EA
Eurasian Patent Office
Prior art keywords
application
cyclic compounds
condensed cyclic
present
glucokinase activator
Prior art date
Application number
EA201071180A
Other languages
English (en)
Other versions
EA019640B1 (ru
Inventor
Цунео Ясума
Нобуюки Такакура
Original Assignee
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед
Publication of EA201071180A1 publication Critical patent/EA201071180A1/ru
Publication of EA019640B1 publication Critical patent/EA019640B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Настоящее изобретение относится к получению активатора глюкокиназы, который можно использовать в качестве фармацевтического средства, такого как средство для профилактики или лечения диабета, ожирения и т.п. Настоящее изобретение предлагает активатор глюкокиназы, содержащий соединение, имеющее формулу (I)где все символы имеют значения, определенные в описании, или его соль или пролекарство.
EA201071180A 2008-04-10 2009-04-09 Производные индола и их применение в качестве активаторов глюкокиназы EA019640B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008102691 2008-04-10
PCT/JP2009/057625 WO2009125873A1 (en) 2008-04-10 2009-04-09 Fused ring compounds and use thereof

Publications (2)

Publication Number Publication Date
EA201071180A1 true EA201071180A1 (ru) 2011-04-29
EA019640B1 EA019640B1 (ru) 2014-05-30

Family

ID=40671202

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201071180A EA019640B1 (ru) 2008-04-10 2009-04-09 Производные индола и их применение в качестве активаторов глюкокиназы

Country Status (35)

Country Link
US (1) US8673942B2 (ru)
EP (1) EP2276760B1 (ru)
JP (1) JP5528348B2 (ru)
KR (1) KR20110002472A (ru)
CN (1) CN102056924B (ru)
AR (1) AR073609A1 (ru)
AU (1) AU2009234666B2 (ru)
BR (1) BRPI0910912A2 (ru)
CA (1) CA2720686A1 (ru)
CO (1) CO6321240A2 (ru)
CR (1) CR11730A (ru)
CY (1) CY1115247T1 (ru)
DK (1) DK2276760T3 (ru)
DO (1) DOP2010000301A (ru)
EA (1) EA019640B1 (ru)
EC (1) ECSP10010602A (ru)
ES (1) ES2476265T3 (ru)
GE (1) GEP20135846B (ru)
HK (1) HK1152932A1 (ru)
HR (1) HRP20140588T1 (ru)
IL (1) IL208463A (ru)
MA (1) MA32283B1 (ru)
ME (1) ME01887B (ru)
MX (1) MX2010011138A (ru)
MY (1) MY152475A (ru)
NZ (1) NZ588562A (ru)
PE (1) PE20100734A1 (ru)
PL (1) PL2276760T3 (ru)
PT (1) PT2276760E (ru)
RS (1) RS53378B (ru)
SI (1) SI2276760T1 (ru)
UA (1) UA104422C2 (ru)
UY (1) UY32131A (ru)
WO (1) WO2009125873A1 (ru)
ZA (1) ZA201007682B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2371826A4 (en) 2008-12-29 2012-06-27 Takeda Pharmaceutical NEW CONNECTION WITH CONDENSED RINGS AND ITS USE
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2014085486A2 (en) 2012-11-30 2014-06-05 Waters Technologies Corporation Methods and apparatus for the analysis of vitamin d metabolites
US9453038B2 (en) 2012-12-17 2016-09-27 Merck Sharp & Dohme Corp. Glucokinase activator compounds, compositions containing such compounds, and methods of treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05505612A (ja) 1991-03-01 1993-08-19 ハー・ルンドベック・アクティーゼルスカブ 高血圧症及び末梢血管疾患の治療法
US6506901B2 (en) * 2000-07-17 2003-01-14 Wyeth Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonists
CN101103977A (zh) * 2002-06-05 2008-01-16 株式会社医药分子设计研究所 糖尿病治疗药
EP1532980A1 (en) 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
WO2006089397A1 (en) 2005-02-22 2006-08-31 Gemin X Biotechnologies Inc. Methods for treating arthritis using triheterocyclic compounds
EP1873144B1 (en) * 2005-04-20 2014-07-23 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
US7799820B2 (en) * 2005-09-30 2010-09-21 Banyu Pharmaceutical Co., Ltd. 2-Heterocycle-substituted indole derivatives for treating diabetes and associated conditions
JP5260507B2 (ja) 2006-10-19 2013-08-14 武田薬品工業株式会社 インドール化合物
WO2009025478A1 (en) * 2007-08-17 2009-02-26 Lg Life Sciences Ltd. Indole and indazole compounds as an inhibitor of cellular necrosis
EP2220081A4 (en) * 2007-12-20 2011-08-24 Lg Life Sciences Ltd GLUCCOAINEACTIVATORS AND THESE PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE SUBSTANCES
RU2460525C2 (ru) * 2008-01-04 2012-09-10 Эл Джи Лайф Сайенсиз Лтд. Производные индола и индазола, обладающие консервирующим действием по отношению к клеткам, тканям и органам
EP2371826A4 (en) * 2008-12-29 2012-06-27 Takeda Pharmaceutical NEW CONNECTION WITH CONDENSED RINGS AND ITS USE

Also Published As

Publication number Publication date
PT2276760E (pt) 2014-05-28
EA019640B1 (ru) 2014-05-30
NZ588562A (en) 2012-07-27
BRPI0910912A2 (pt) 2015-08-11
UY32131A (es) 2010-11-30
CY1115247T1 (el) 2017-01-04
CO6321240A2 (es) 2011-09-20
ZA201007682B (en) 2011-12-28
IL208463A0 (en) 2010-12-30
MA32283B1 (fr) 2011-05-02
KR20110002472A (ko) 2011-01-07
PE20100734A1 (es) 2010-11-18
MY152475A (en) 2014-10-15
ES2476265T3 (es) 2014-07-14
US20110098297A1 (en) 2011-04-28
IL208463A (en) 2015-07-30
JP2011516403A (ja) 2011-05-26
HRP20140588T1 (hr) 2014-08-01
UA104422C2 (ru) 2014-02-10
PL2276760T3 (pl) 2014-09-30
JP5528348B2 (ja) 2014-06-25
HK1152932A1 (en) 2012-03-16
US8673942B2 (en) 2014-03-18
CA2720686A1 (en) 2009-10-15
EP2276760A1 (en) 2011-01-26
AR073609A1 (es) 2010-11-17
EP2276760B1 (en) 2014-04-09
SI2276760T1 (sl) 2014-05-30
WO2009125873A1 (en) 2009-10-15
ECSP10010602A (es) 2011-03-31
CN102056924A (zh) 2011-05-11
AU2009234666A1 (en) 2009-10-15
AU2009234666B2 (en) 2014-02-20
RS53378B (en) 2014-10-31
DK2276760T3 (da) 2014-05-26
DOP2010000301A (es) 2010-12-31
ME01887B (me) 2014-12-20
CN102056924B (zh) 2014-05-21
GEP20135846B (en) 2013-06-10
MX2010011138A (es) 2010-11-12
CR11730A (es) 2010-12-08

Similar Documents

Publication Publication Date Title
EA201071180A1 (ru) Конденсированные циклические соединения и их применение
EA201270560A1 (ru) Спиропиперидиновые соединения и их фармацевтическое применение для лечения диабета
EA201390794A1 (ru) Бициклическое соединение
EA200970746A1 (ru) Конденсированные циклические соединения в качестве частичных агонистов ppar-гамма
EA201071032A1 (ru) Гетероциклическое соединение
EA201290089A1 (ru) Химические соединения
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
NO20090235L (no) Kondenserte sykliske forbindelser
SMAP201100019A (it) Composti organici.
EA201170772A1 (ru) Органические соединения
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
TN2009000129A1 (en) Indole compound
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
EA201100503A1 (ru) Глюкозидные производные и их применения
EA201290632A1 (ru) Производные бетулина
EA201100007A1 (ru) Производные хиноксалиндиона
MA32727B1 (fr) Pyrazolylaminopyridines au titre d'inhibiteurs de fak
EA201290416A1 (ru) Новые спиропиперидиновые соединения
EA201001404A1 (ru) Амиды 5-оксо-2,3,4,5-тетрагидробензо[b]оксепин-4-карбоновой кислоты и амиды 2,3-дигидробензо[b]оксепин-4-карбоновой кислоты для лечения и предотвращения диабета 1 и 2 типа
EA201171211A1 (ru) Производные оксадиазола
EA201190293A1 (ru) Пролекарства триптолида
PH12012502347A1 (en) Bicyclic compound derivatives and their use as acc inhibitors
EA200970170A1 (ru) Производные 4-триметиламмоний-3-аминобутирата и 4-триметилфосфоний-3-аминобутирата как ингибиторы срт
EA201200868A1 (ru) Ингибиторы диацилглицеролацилтрансферазы
EA202090750A1 (ru) Производные глюконовой кислоты для применения в лечении и/или предупреждении инфекций, вызываемых микроорганизмами

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU